| Document Date: 2015-03-05 03:24:54
Open Document File Size: 304,80 KBShare Result on Facebook
City Copenhagen / / Company Novartis / ADCT / Seattle Genetics / / Country Sweden / Denmark / / Currency USD / DKK / EUR / / / Event FDA Phase / / IndustryTerm therapy of cancer / online network / online dialogue / online chat communication / financial media / generation technologies / investor meetings / online marketing / / Person JAN VAN DE WINKEL Q / Jan Van de Winkel Genmab / Janssen / JAN VAN DE WINKEL / Jan Van de Winkel Janssen / David Eatwell / Daratumumab / / / Position CEO / private investor / CFO / / Product Humax-TF ADC / Dara+VTD / ADC compounds / AXL-ADC / NHL / / ProvinceOrState Indiana / / RadioStation 2015 WITH / / SportsEvent NHL / the NHL / / Technology ADC / generation technologies / artificial intelligence / UltiMab technology / / URL www.tcpdf.org / www.proinvestor.com/ir/en / /
SocialTag |
Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL Q&A GENMAB 4TH OF MARCH 2015